Human METCAM/MUC18 as a Novel Biomarker to Drive and Its Specific SiRNAs to Block the Malignant Progression of Prostate Cancer

Journal of Cell Science & Therapy
doi 10.4172/2157-7013.1000227
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

N-Cadherin, a Novel Prognostic Biomarker, Drives Malignant Progression of Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

AKR1C3 Overexpression May Serve as a Promising Biomarker for Prostate Cancer Progression

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2014English

PGC1α Drives a Metabolic Block on Prostate Cancer Progression

Nature Cell Biology
Cell Biology
2016English

Splice Variant PRKC-ζ-PrC Is a Novel Biomarker of Human Prostate Cancer

British Journal of Cancer
Cancer ResearchOncology
2012English

Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer

Anticancer Research
MedicineCancer ResearchOncology
2020English

A Novel Human AlkB Homologue, ALKBH8, Contributes to Human Bladder Cancer Progression

Cancer Research
Cancer ResearchOncology
2009English

The Novel Prostate Cancer Antigen 3 (PCA3) Biomarker

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2010English

SMAGP a Novel Biomarker of Cervical Cancer Development and Progression [Erratum]

OncoTargets and Therapy
OncologyPharmacology
2020English

KLF4, a Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy